| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marjan Alizadeh Asfestani, Valentin Brechtmann, João Santiago, Andreas Peter, Jan Born, Gordon Benedikt Fel. Consolidation of Reward Memory during Sleep Does Not Require Dopaminergic Activation. Journal of cognitive neuroscience. vol 32. issue 9. 2021-10-28. PMID:32459129. |
although dopamine has been shown to be a key determinant during reward learning, the role of dopaminergic neurotransmission for amplifying reward-related memories during sleep remains unclear. |
2021-10-28 |
2023-08-13 |
human |
| Ramón Cacabelos, Iván Carrera, Olaia Martínez, Ramón Alejo, Lucía Fernández-Novoa, Pablo Cacabelos, Lola Corzo, Susana Rodríguez, Margarita Alcaraz, Laura Nebril, Iván Tellado, Natalia Cacabelos, Rocío Pego, Vinogran Naidoo, Juan C Carri. Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics. Medicinal research reviews. vol 41. issue 5. 2021-10-28. PMID:34106485. |
atremorine is a potent dopamine (da) enhancer with powerful effects on the neuronal dopaminergic system, acting as a neuroprotective agent in parkinson's disease (pd). |
2021-10-28 |
2023-08-13 |
Not clear |
| Lena F Burbulla, Jianbin Zheng, Pingping Song, Weilan Jiang, Michaela E Johnson, Patrik Brundin, Dimitri Krain. Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson's disease models. JCI insight. vol 6. issue 19. 2021-10-28. PMID:34622801. |
moreover, quetiapine treatment of induced pluripotent stem cell-derived (ipsc-derived) dopaminergic neurons from patients carrying mutations in gba1 or lrrk2 led to increased wild-type gcase protein levels and activity and partially lowered accumulation of oxidized dopamine, glucosylceramide, and α-synuclein. |
2021-10-28 |
2023-08-13 |
mouse |
| Andres Damian, Maria M Pineyro, Adriana Quagliata, Mariana Risso, Paula Montiglia, Ramiro Lima, Omar Alons. World journal of nuclear medicine. vol 20. issue 3. 2021-10-28. PMID:34703398. |
some studies have assessed the expression of dopaminergic dopamine 2 (d2)/3 receptors in prolactinomas and nonfunctioning pituitary adenomas (nfpa) by positron emission tomography/computed tomography (pet/ct) with |
2021-10-28 |
2023-08-13 |
Not clear |
| Zhou Ou, Yuanzhang Zhou, Lijun Wang, Liujun Xue, Jinlong Zheng, Liam Chen, Qiang Ton. NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice. Molecular neurobiology. vol 58. issue 4. 2021-10-27. PMID:33169332. |
our results show that nlrp3 inflammasome inhibition via nlrp3 knockout not only protects against nigral dopaminergic degeneration and striatal dopamine deletion but also prevents nigral pathological α-synuclein formation in pd mice. |
2021-10-27 |
2023-08-13 |
mouse |
| Angel Toval, Daniel Garrigos, Yevheniy Kutsenko, Miroljub Popović, Bruno Ribeiro Do-Couto, Nicanor Morales-Delgado, Kuei Y Tseng, José Luis Ferra. Dopaminergic Modulation of Forced Running Performance in Adolescent Rats: Role of Striatal D1 and Extra-striatal D2 Dopamine Receptors. Molecular neurobiology. vol 58. issue 4. 2021-10-27. PMID:33394335. |
dopaminergic modulation of forced running performance in adolescent rats: role of striatal d1 and extra-striatal d2 dopamine receptors. |
2021-10-27 |
2023-08-13 |
rat |
| Edina Szűcs, Eszter Ducza, Alexandra Büki, Gabriella Kekesi, Sándor Benyhe, Gyöngyi Horvat. Characterization of dopamine D Brain research. vol 1748. 2021-10-26. PMID:32858029. |
as the dopamine hypothesis of schizophrenia is central to research in the field, the goal of the present study was to investigate dopaminergic d |
2021-10-26 |
2023-08-13 |
rat |
| Eslam El Nebris. Neuroprotective Activities of Curcumin in Parkinson's Disease: A Review of the Literature. International journal of molecular sciences. vol 22. issue 20. 2021-10-26. PMID:34681908. |
parkinson's disease (pd) is a slowly progressive multisystem disorder affecting dopaminergic neurons of the substantia nigra pars compacta (snpc), which is characterized by a decrease of dopamine (da) in their striatal terminals. |
2021-10-26 |
2023-08-13 |
Not clear |
| Juan Pérez-Fernández, Marta Barandela, Cecilia Jiménez-Lópe. The Dopaminergic Control of Movement-Evolutionary Considerations. International journal of molecular sciences. vol 22. issue 20. 2021-10-26. PMID:34681941. |
dopamine is likely the most studied modulatory neurotransmitter, in great part due to characteristic motor deficits in parkinson's disease that arise after the degeneration of the dopaminergic neurons in the substantia nigra |
2021-10-26 |
2023-08-13 |
Not clear |
| Katie Pizzolato, David Thacker, Nicole Del Toro-Pagán, Abeer Hanna, Jacques Turgeon, Adriana Matos, Nishita Amin, Veronique Michau. Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson's Disease. Medicina (Kaunas, Lithuania). vol 57. issue 10. 2021-10-26. PMID:34684144. |
thc elicits psychoactive effects through modulation of dopaminergic neurons, thereby altering levels of dopamine in the brain. |
2021-10-26 |
2023-08-13 |
Not clear |
| Teresa Katthagen, Jakob Kaminski, Andreas Heinz, Ralph Buchert, Florian Schlagenhau. Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients. Schizophrenia bulletin. vol 46. issue 6. 2021-10-25. PMID:32318717. |
it has been proposed that heightened striatal dopamine may blunt dopaminergic reward prediction error signaling during reinforcement learning. |
2021-10-25 |
2023-08-13 |
Not clear |
| N P Kurzina, I Y Aristova, A B Volnova, R R Gainetdino. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze. Behavioural brain research. vol 390. 2021-10-25. PMID:32428629. |
one of the most useful animal models for dopaminergic dysregulation is the strain of dopamine transporter knockout (dat-ko) rats that have no dopamine re-uptake and thus elevated extracellular dopamine levels. |
2021-10-25 |
2023-08-13 |
rat |
| Ryota Bando, Hideki Otsuka, Tamaki Otani, Noritake Matsuda, Shota Azane, Yamato Kunikane, Yoichi Otomi, Wataru Sako, Yuishin Izumi, Masafumi Harad. A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography. Annals of nuclear medicine. vol 35. issue 4. 2021-10-25. PMID:33630226. |
using the standardized uptake value (suv) of dat spect, we propose "functional dopamine transporter volume (f-dtv)" as a new quantitative index to evaluate the three-dimensional volume of functional dopamine transporters and assess its diagnostic ability in differentiating dopaminergic neurodegenerative diseases (dndd) from non-dndd. |
2021-10-25 |
2023-08-13 |
Not clear |
| Sanjeev K Bhardwaj, Qiming Cui, Luc Moquin, Alain Gratton, Bruno Giros, Lalit K Srivastav. Mice with dopaminergic neuron-specific deletion of DTNBP-1 gene show blunted nucleus accumbens dopamine release and associated behaviors. Neuropharmacology. vol 184. 2021-10-22. PMID:33340529. |
mice with dopaminergic neuron-specific deletion of dtnbp-1 gene show blunted nucleus accumbens dopamine release and associated behaviors. |
2021-10-22 |
2023-08-13 |
mouse |
| Mareike Fauser, Francisco Pan-Montojo, Christian Richter, Philipp J Kahle, Sigrid C Schwarz, Johannes Schwarz, Alexander Storch, Andreas Herman. Chronic-Progressive Dopaminergic Deficiency Does Not Induce Midbrain Neurogenesis. Cells. vol 10. issue 4. 2021-10-22. PMID:33807497. |
dopamine is a known modulator of adult neural stem cell (ansc) proliferation and dopaminergic neurogenesis in the olfactory bulb, though a possible interplay between local dopaminergic neurodegeneration and induction of ansc proliferation in mid/hindbrain pvrs is currently enigmatic. |
2021-10-22 |
2023-08-13 |
Not clear |
| Angel Carvajal-Oliveros, Carmen Domínguez-Baleón, Rafaella V Zárate, Jorge M Campusano, Verónica Narváez-Padilla, Enrique Reynau. Nicotine suppresses Parkinson's disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels. Scientific reports. vol 11. issue 1. 2021-10-22. PMID:33953275. |
nicotine is beneficial on fly survival and motility increasing tyrosine hydroxylase and dopamine levels, suggesting that cholinergic agonists may promote survival and metabolic function of the dopaminergic neurons that express sph-1. |
2021-10-22 |
2023-08-13 |
drosophila_melanogaster |
| Mingzheng Wu, Samuel Minkowicz, Vasin Dumrongprechachan, Pauline Hamilton, Lei Xiao, Yevgenia Kozorovitski. Attenuated dopamine signaling after aversive learning is restored by ketamine to rescue escape actions. eLife. vol 10. 2021-10-21. PMID:33904412. |
rather than directly altering the activity of dopaminergic neurons, ketamine appears to rescue dopamine dynamics through actions in the medial prefrontal cortex (mpfc). |
2021-10-21 |
2023-08-13 |
mouse |
| Lucile Cathiard, Valerie Fraulob, Daniel D Lam, Miguel Torres, Juliane Winkelmann, Wojciech Kręże. Investigation of dopaminergic signalling in Meis homeobox 1 (Meis1) deficient mice as an animal model of restless legs syndrome. Journal of sleep research. vol 30. issue 5. 2021-10-21. PMID:34008292. |
the efficacy of dopaminergic agonists, including dopamine d |
2021-10-21 |
2023-08-13 |
mouse |
| Giuseppina Natale, Annabella Pignataro, Gioia Marino, Federica Campanelli, Valeria Calabrese, Antonella Cardinale, Silvia Pelucchi, Elena Marcello, Fabrizio Gardoni, Maria Teresa Viscomi, Barbara Picconi, Martine Ammassari-Teule, Paolo Calabresi, Veronica Ghiglier. Transcranial Magnetic Stimulation Exerts "Rejuvenation" Effects on Corticostriatal Synapses after Partial Dopamine Depletion. Movement disorders : official journal of the Movement Disorder Society. vol 36. issue 10. 2021-10-21. PMID:34339069. |
repetitive transcranial magnetic stimulation (rtms) induces modifications in glutamatergic and dopaminergic systems, suggesting that it may have an impact on glutamatergic synapses modulated by dopamine neurotransmission. |
2021-10-21 |
2023-08-13 |
Not clear |
| James W Bales, Anthony E Kline, Amy K Wagner, C Edward Dixo. Targeting Dopamine in Acute Traumatic Brain Injury. The open drug discovery journal. vol 2. 2021-10-21. PMID:22308176. |
the purpose of this review is to discuss dopamine in acute tbi and the role that dopaminergic therapies have as neuroprotective strategies. |
2021-10-21 |
2023-08-12 |
Not clear |